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Abstract 
This study examined the relationship among health expenditure, health outcomes and 
economic growth in Nigeria for the period between 1981 and 2017. This study adopted the 
Toda-Yamamoto causality framework to examine these relationships. The Augmented 
Dickey Fuller unit root test was used to check for maximum order of integration of the 
variables used in the study and the result was one while the Autoregressive Distributed Lag 
(ARDL) Bounds test approach to cointegration was used to investigate if a long-run 
relationship exists among the macroeconomic variables used in the study and the result was 
in the affirmative. The results of the Toda-Yamamoto causality tests showed a unidirectional 
causality running from health expenditure to infant mortality while there is no causality 
between real GDP and infant mortality; a unidirectional causal relationship running from 
health expenditure and real GDP to life expectancy and maternal mortality; and a 
unidirectional causal relationship running from real GDP to health expenditure. This study 
therefore recommended that the Nigerian government should make concerted efforts geared 
towards increasing the health expenditure at least to meet up with the WHO‟s 
recommendation that all countries should allocate at least 13 per cent of their annual budget 
to the health sector for effective funding as this would bring desired health outcomes and 
employ the use of modern technology and the services of professional health personnel 
should be sought to combat the high incidence of maternal and infant mortality in the health 
sector in Nigeria. 
 
Keywords: Health Expenditure, Life Expectancy, Infant Mortality, Maternal Mortality, Toda-
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1.0 Introduction 
The state of health of the population of a country is a major factor driving productivity as 
only a healthy labour force can make meaningful contributions to production and growth of 
national output. As is the case in a typical production function, the quantity / level of inputs 
has a corresponding effect on the quantity / level of output depending on the scale of 
production and returns to scale. Hence, this make the health of the citizens of a country 
imperative and as such adequate provision for health should be one of the primary goals of 
government as it has a positive impact on economic growth, one of the macroeconomic goals 
of every government.  
Similarly, the health of the population is influenced by both the type of health system and of 
their resources. The relationship between resources and outcomes helps one to effectively 
assess how functional the health system of a country is. A country has a health system with a 
better performance than another country, if, for the same level of resources, it generates better 
health outcomes, or if it generates the same outcomes but with fewer resources (Elola et al., 
1995). Health systems are financed either through taxes, in the case of healthcare services 
owned by the state (national health services), or through income-related social contributions 
(social security systems) (Elola et al., 1995). The contribution of social security to the 
sustenance of the finance of the health system is phenomenal in countries with high income 
per capita. 
It is one of the major duties of every government to provide funds for the provision of social 
welfare of which health care is an integral part. Thus, government devotes public fund to the 
provision of health care services in a bid to improving the health of the citizenry so as to 
enable them make significant contributions to economic growth and development in the 
country. It is believed that an increase in budgetary allocation to social services should 
enhance service delivery but this is not the case in Nigeria. In many developing countries, 
budget misappropriation and/or mismanagement is one of the primary causes of ineffective 
public spending (World Bank, 1998). For instance, many health indicators show that Nigeria 
ranks low in health status despite the increasing budgetary allocation to the health sector. 
UNAIDS, in 2016, ranked Nigeria as the second largest country with the prevalence of 
HIV/AIDS in the world. In 2017, Central Intelligence Agency (CIA) also ranked Nigeria as 
the eighth country with the highest infant mortality rate (69.8 per 1000 live birth) in the 
world. Furthermore, the United Nations Department of Economic and Social Affairs (UN 
DESA) says Nigeria‟s life expectancy stands at 52.29 years, the 194th in the world.  
This statistics is indicative of the fact that the expenditure on health is not enough to develop 
the health system of Nigeria or appropriate policies are not put in place to improve the health 
system of the country. The cost of health is on the high side and in a bid to bridge the huge 
health funding gap by governments to its citizens, especially in developing and 
underdeveloped countries, the WHO recommended that countries should allocate at least 13 
per cent of their annual budget to the health sector for effective funding. All member 
countries, including Nigeria signed towards the recommendation. Also, an Abuja Declaration, 
signed in 2001 by all member countries of the African Union, including Nigeria, who in fact 
was the host of the high powered meeting, recommended that for the continent to be at par 
with other nations of the world in terms of healthcare provision, 15 per cent of their annual 
budget, at the least, be allocated to the health sector. However, the budgetary allocation to the 
health sector (government health expenditure) has been below par over time implying that a 
large percentage of healthcare services will be funded from out-of-pocket which majority of 
Nigerians cannot afford.  
3 
 
The Nigerian economy is highly import-dependent not only on goods but also on services to 
the extent that her political office holders as well as the rich import medical services either by 
employing the services of foreign medical experts to Nigeria or travelling abroad for medical 
check-up and/or treatment thereby enriching foreign nations at the expense of the domestic 
economy. For instance, the present president of Nigeria, Muhammadu Buhari, went on 
medical vacation in early 2017 for over 50 days after which he went for another medical 
vacation for a staggering 103 days in May, 2017. This attitude by the president, other 
politicians and the rich alike shows that they do not believe in the services rendered by 
resident medical practitioners as most of the equipment and machines used in Nigerian are 
outdated and cannot measure up to what obtains in developed countries of the world. 
Consequently, there is an increase in brain-drain as competent medical personnel migrate to 
developed countries of the world, where sophisticated medical equipment and machines are 
available, to enhance their productivity and keep up with the pace of development in the 
medicine. Consequently, this reduces the labour force in the health sector thereby reducing 
the sector‟s contribution to GDP and the aggregate national output at large. 
Several policies and institution frameworks have been instituted to improve the performance 
of the Nigerian health sector overtime. These policies include: National Population Policy of 
1988, National Population Policy for Sustainable Development of 2004 and the National 
Population Policy of 2006. The institutional frameworks include: The National Population 
Commission (NPC), The National Planning Commission and the Federal Ministry of Health 
which comprises of four agencies whose activities directly or indirectly affect the 
demographic structure of Nigeria namely: the National Primary Health Care Development 
Agency (NPHCDA), the National Health Insurance Scheme (NHIS), the Nigerian Institute of 
Medical Research (NIMR) and the National Agency for Food and Drug Administration and 
Control (NAFDAC). However, these efforts of the government have not yielded the desired 
results given the maladies bedeviling the Nigerian health sector. 
The literature is replete with studies on the issues relating to public health expenditure and 
health outcomes in different countries of the world [Kim and Lane, 2013 (17 OECD 
Countries); Novignon et al, 2012 (44 Sub-Sahara African Countries); Anyanwu and 
Erhijakpor, 2007 (47 African Countries); Elola et al, 1995 (17 Western European Countries); 
Novignon and Lawanson, 2016 (45 Sub-Saharan African Countries); Kulkarni, 2016 (BRICS 
Countries); Deluna and Peralta, 2014 (Philippines), Day and Tousignant, 2005 (Canada); 
Becchetti et al, 2015 (European countries); Jaba et al, 2014 (175 World Countries); 
Ogungbenle et al, 2013 (Nigeria); Edeme et al, 2017 (Nigeria); among other]. While some 
studies [Jaba et al (2014); and Ogungbenle et al, 2013] focused on the impact of health 
expenditure on life expectancy, some focused on the relationship between public health 
expenditure and mortality rate which are the only a small fraction of the overall health 
indicators/outcomes of an economy. Hence, the literature contains only a few studies on the 
empirical examination of the relationship between public health expenditure and health 
outcomes using only about two health indicator as a proxy for health outcome. This study 
will take a panoramic view of the health outcomes/indicators of an average household in the 
Nigerian economy by examining the relationship between public health expenditure and three 
major health outcomes (life expectancy, infant mortality, and maternal mortality) in Nigeria 
and also extend the analysis to investigating the impact of these health outcomes on the 
growth of the Nigerian economy. Another novelty of this study lies in the fact that it employs 
the use of the Toda-Yamamoto causality test to examine the relationship among health 
expenditure, health outcomes and economic growth, a technique that is particularly rare in the 
extant literature.  
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It is against this background that this study will empirically investigate the relationship 
between health expenditure and health outcomes as well as the impact of health outcomes on 
economic growth in Nigeria for the period between 1981 and 2016. It also checks for the 
direction of causal relationship of these macroeconomic variables. The rest of this paper is 
structured in the following manner: Section 2 discusses the trend analysis of key variables; 
Section 3 comprises the review of related studies; Section 4 contains the methodology, model 
specification and empirical analysis; and Section 5 concludes the study. 
2.0 Health Expenditure, Health Outcomes and Real GDP Profile in Nigeria 
Figure 2.1 presents the profile of government expenditure on health and the corresponding 
health outcomes as well as the real GDP of Nigeria. A cursory look at Figure 2.1 reveals that 
government expenditure on health fluctuated for most the period under review even though 
there was a significant increase in it during the period. It grew steadily from N0.80 billion in 
1981 to N0.62 billion in 1991, plummeted the following year to N0.15 billion and grew 
sharply to N3.87 billion in 1993 after which it fluctuated but stood at N16.64 billion in 1999. 
However, it is noteworthy that it grew markedly by about 134 percent from N99.1 billion in 
2010 to N231.8 billion in 2011 from when it plummeted and stood at N202.36 billion in 
2016. On the other hand, the share of health expenditure in total government expenditure 
stabilized at 1.74 percent from 1981 to 1986 but fell sharply to 0.26 percent in 1987 from 
when it rose to stand between 2.3 – 3.7 percent from 1993 – 2000. Moreover, it grew to 4 and 
5 percent in 2001 and 2002 respectively. The highest share of health expenditure in total 
government expenditure was in 2011 when it stood at 6.99 percent which falls short of the 
WHO recommendation as well as 2001 Abuja Declaration of the African Union that 
countries should allocate at least 13 per cent of their annual budget to the health sector for 
effective funding. This indicates that Nigeria falls below par in the expected expenditure on 
health. 
In addition, it is obvious that real GDP grew steadily almost throughout the period under 
review except for a few years (1982-1984 and 2016). The Nigerian economy plunged into 
economic crises during these periods and the Bretton Woods institutions, in a bid to salvage 
the Nigerian economy in the 1980s, introduced the Structural Adjustment Programmes (SAP) 
to Nigeria which later aggravated the economic crises it was meant to solve. Also, the 
Nigerian economy plunged into a recession in recently (2016) when her real GDP fell from 
N69023 billion in 2015 to N67931 billion in 2016.  
Figure 2.1 also shows that infant mortality rate stood at 125.4 per 1,000 live births in 1981 
but declined to 124 per 1,000 live births in 1983 and increased steadily to 126.2 in 1989 and 
1990. However, it plummeted in 126 per 1,000 live births in 1991 from when it decreased 
steadily until it reached a double figure of 99.8 per 1,000 live births in 2004 and stood at 81.1 
and 66.9 per 1,000 live births in 2010 and 2016 respectively. This downward trend could be 
linked to the advancement in medical science. In the same vein, maternal mortality rate stood 
at 362.41 per 1,000 female adults in 1981 and it fluctuated from then till 1993 when it stood 
at 363.8 per 1,000 female adults. It however increased steadily to 393.53 per 1,000 female 
adults in 2002 but declined from then until it reached 359.82 and 333.03 per 1,000 female 
adults in 2010 and 2016 respectively. This indicates that the effort of the Nigerian 
government in combating maternal mortality is yielding the desired fruit. 
Additionally, life expectancy at birth in Nigeria stood at 45.62 years in 1981 increased 
steadily to 46.13 in 1985. It however declined to 45.84 years in 1993 and 1994 but increase in 
1995 to 48.25 years and has since then maintained an upward trend till it reached 48.25 years, 
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50.85 years and 53.43 years in 2005, 2010 and 2016 respectively. Figure 2.1 reveals that life 
expectancy at birth is relatively stable throughout the period under review. It is also apparent 
that infant mortality as well as maternal mortality rose for some time but declined gradually 
for most part of the period under review. On the other hand, real GDP maintained an upward 
trend almost throughout the period under review while government health expenditure had 
some spikes and also grew for most part of the period under review but fell in 2016 when 
Nigeria plunged into a recession. This suggests that the recession in Nigeria in 2016 reduced 
government expenditure on health. 
Figure 2.2: Trends of Health Expenditure, Health Outcomes and Real GDP in Nigeria 
 
Source: Author‟s Computation from CBN Statistical Bulletin (2017) and WDI (2018) 
3.0 Literature Review 
There is a plethora of time-series and panel studies examining the nexus among health 
expenditure, health outcomes and economic growth. For instance, Dormont, Martins, Pelgrin 
and Suhrcke (2007) adopted the Pooled OLS, fixed effect and random effect models to 
examine the relationships between health spending, medical innovation, health status, growth 
and welfare and found that health spending triggers technological progress, which is a 
potential source of better outcomes in terms of longevity and quality of life, a direct source of 
growth for the bio-tech industries and an indirect source of growth through improved of 
human capital. The latter contributes to GDP per capita through two main channels: higher 
participation of the population in the labour force and higher labour productivity levels. In 
turn, income growth induces an increase in health expenditure, as richer countries tend to 
spend a higher share of their income on health.  
Becchetti, Conzo and Salustri (2015) investigated the impact of health expenditure on health 
outcomes on a large sample of Europeans aged above 50 using individual and regional-level 
data. The results showed that health expenditure to GDP and health expenditure per capita 
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have a negative and significant impact on changes in the number of chronic diseases. It also 
showed that health expenditure produces heterogeneous effects on health outcomes, being 
more relevant for the elders, females, the overweight/obese, the below-median income group 
and for the less-educated vis-à-vis their complementary samples. After controlling for real 
per capita income, literacy level, and female participation in the labour market, Boachie and 
Ramu (2015) adopted the OLS and Newey-west estimation techniques and found evidence 
that the declining or falling infant mortality rate in Ghana has been influenced by public 
health spending among other factors.  
Kulkarni (2016) used the panel data regression with fixed effects model to examine the 
differences in the health care systems of Brazil, India, China, Russian Federation and South 
Africa, the emerging economies of BRICS. The results show a positive relation between 
health outcome and the GDP per capita, adult literacy rate, and out-of-pocket expenditure; 
environmental pollution has a negative relation with health outcomes; and age dependency 
ratio and public health expenditure also show a positive elasticity with infant mortality rate. 
Kim and Lane (2013) analyzed the relationship between public health expenditure and 
national health outcomes among developed countries. The findings showed a negative 
relationship between government health expenditure and infant mortality rate, and a positive 
relationship between government health expenditure and life expectancy at birth. Jaba, 
Balana and Robu (2014) analyzed the relationship between the dynamics of the inputs and the 
outputs of health care systems and found that there is a significant relationship between 
health expenditures and life expectancy and that country effects are significant and show the 
existence of important differences among the countries. 
In their study, Deluna and Peralta (2014) examined the relationship among public health 
expenditures, income and health outcomes in the Philippines. The results showed that infant 
mortality rate is inversely related to health expenditure per capita and GDP per capita. In their 
study on the dynamic analysis of the relationship among health spending, health outcomes 
and per capita income in Canada, Day and Tousignant (2005) employed the vector 
autoregression (VAR) model and the generalized impulse response function estimation 
technique and found evidence of a weak statistically significant relationship between per 
capita health spending, health outcomes, and per capita GDP. Gani (2009) examined the 
relationship between per capita public health expenditure and three measures of health 
outcomes for seven Pacific Island countries. The result provided strong evidence that per 
capita health expenditure is an important factor in determining health outcomes. The 
empirical results also provide strong evidence that per capita incomes and immunization are 
additional core factors that determine health outcomes.  
Novignon and Lawanson (2016) sought to understand the relationship between child health 
outcomes and health spending while investigating lagged effects. The results show a positive 
and significant relationship between health expenditure and child health outcomes. Public 
health expenditure was found to be relatively more significant than private expenditure. 
Novignon, Olakojo and Novignon (2012) employed the fixed and random effects panel data 
regression model estimation techniques to assess the effect of health care expenditure on 
population health status and to examine the effect by public and private expenditure sources. 
The results show that health care expenditure significantly influences health status through 
improving life expectancy at birth, reducing death and infant mortality rates. Both public and 
private health care spending showed strong positive association with health status even 
though public health care spending had relatively higher impact. Edeme, Emecheta and 
Omeje (2017) investigated the effect of public health expenditure on health outcomes in 
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Nigeria and found that an increase in public health expenditure improves life expectancy and 
reduces infant mortality rates. 
Anyanwu and Erhijakpor (2007) employed the Robust Ordinary Least Squares (ROLS) 
model and Robust Two-Stage Least Squares (R2SLS) techniques to provide econometric 
evidence linking African countries‟ per capita total as well as government health expenditures 
and per capita income to infant mortality and under-five mortality. Health expenditures have 
a statistically significant effect on infant mortality and under-five mortality. In addition, both 
infant and under-five mortality are positively and significantly associated with Sub-Saharan 
Africa while the reverse is true for North Africa. Piabuo and Tieguhong (2017) conducted a 
comparative analysis on the impact of health expenditure between countries in the CEMAC 
sub-region and five other African countries that achieved the Abuja declaration. The results 
showed that health expenditure has a positive and significant effect on economic growth in 
both samples. In addition, a long-run relationship also exists between health expenditure and 
economic growth for both groups of countries. 
Matthew, Adegboye and Fasina (2015) adopted the vector error correction model to examine 
government spending on health and its effect on health outcomes in Nigeria and found that 
public spending on health has a significant relationship with health outcomes in Nigeria and 
that environmental factors such as carbon dioxide emissions affects individuals‟ health. 
Similarly, Nwanosike, Orji, Okafor and Umesiobi (2015) employed the ordinary least square 
estimation technique to investigate the progressive implication of malaria incidence and 
malaria spending on Nigeria health outcomes and found that increase in health expenditure 
and educational expenditure reduce malaria incidence. Yaqub, Ojapinwa and Yussuff (2012) 
used the Ordinary Least Squares and the Two-Stage Least Squares estimation techniques to 
investigate how the effectiveness of public health expenditure is affected by governance in 
Nigeria and found that public health expenditure has negative effect on infant mortality and 
under-5 mortalities when the governance indicators are included. Maduka, Madichie and 
Ekesiobi (2006) examined the relationship among government health expenditure, health 
outcomes and economic growth in Nigeria using the using Toda and Yamamoto causality 
approach. The results revealed that government health expenditures indirectly influence 
economic growth through health outcomes such as mortality rate and life expectancy. 
In their empirical analysis of the relationship existing among life expectancy, public health 
spending and economic growth in Nigeria, Ogungbenle, Olawumi and Obasuyi (2013) found 
that there is no bi-directional causality between life expectancy and public health spending in 
Nigeria neither is a bi-directional causality between life expectancy and economic growth in 
Nigeria over the years. However, the study confirmed that there is bi-directional causality 
between public health spending and economic growth in Nigeria. Hooda (2014) examined the 
impact of different decentralized governance measures on infant and child mortality rates of 
rural India across states and in improving the efficacy of rural health spending. The result 
showed that states with high fiscal and political decentralisation have more significant impact 
in reducing the infant mortality compared to states having high fiscal but low political 
decentralisation, indicating efficacy of fiscal decentralisation increases with political 
decentralisation. 
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4.0 Methodology, Model Specification and Empirical Analysis 
4.1 Methodology and Model Specification  
This study assesses the relationship among health expenditure, health outcomes and 
economic growth in Nigeria for the period between 1981 and 2016 using the Toda-
Yamamoto causality test. The aim is to examine how health expenditure influences health 
outcome and economic growth; how health outcomes influence health outcome and economic 
growth; and how economic growth influences health expenditure and health outcome. 
Whereas government expenditure on health is used as a proxy for health expenditure, real 
GDP growth is used as proxy for economic growth and the variables of health outcomes for 
this study include: life expectancy, infant mortality and maternal mortality. Data for the 
period between 1981 and 2017 on infant mortality, life expectancy and maternal mortality are 
sourced from World Development Indicators (2018) while data on health expenditure and 
real GDP are sourced from Central Bank of Nigeria (CBN) Statistical Bulletin (2017). 
Following (Wolde-Rufael 2005) and Maduka, Madichie and Ekesiobi (2016), this study 
employs the Granger non-causality test, a Toda–Yamamoto procedure that is applicable 
regardless of whether a series is I(0), I(1), or I(2), non-cointegrated or cointegrated of any 
order. This implies that it avoids the potential bias associated with unit root and cointegration 
tests. As pointed out by Clarke and Mirza (2006), pre-tests for unit root and cointegration 
might suffer from size distortion, which often implies the use of an inaccurate model for the 
non-causality test. To obviate some of these problems, the Toda-Yamamoto test, based on 
augmented VAR modeling, introduced a Wald test statistic that asymptotically has a chi-
square distribution irrespective of the order of integration or cointegration properties of the 
variables. The Toda–Yamamoto approach ﬁts a standard vector autoregression and a vector 
error correction model on levels of the variables (not on their ﬁrst differences) and therefore 
makes allowances for the long-run information often ignored in systems that require ﬁrst 
differencing and pre-whitening (Clarke and Mirza, 2006). The approach employs a modiﬁed 
Wald test (MWALD) for restrictions on the parameters of the VAR (k), where k is the lag 
length of the system. The basic idea of the Toda-Yamamoto approach is to artiﬁcially 
augment the correct order, k, by the maximal order of integration, say dmax. Once this is done, 
a (k + dmax) the order of VAR is estimated and the coefﬁcients of the last lagged dmax vectors 
are ignored. 
Based on the foregoing and following the specification of Maduka, Madichie and Ekesiobi 
(2016), the relationship between health expenditure, health outcomes and economic growth 
are represented mathematically as follows: 
LEXP = f (HEXP, RGDP) -- -- -- -- -- -- (4.1) 
IFM = f (HEXP, RGDP) -- -- -- -- -- -- (4.2) 
MMT = f (HEXP, RGDP) -- -- -- -- -- -- (4.3) 
RDGP = f (HEXP, LEXP, IFM, MMT, FTR) -- -- -- (4.4) 
HEXP = f (RGDP, LEXP, IFM, MMT, FTR) -- -- -- (4.5) 
The econometric representations of the above mathematical equations are as follow:  
LEXP = α0 + α1HEXP + α2RGDP + 𝜺1 -- -- -- -- (4.6) 
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IFM = β0 + β1HEXP + β2RGDP + 𝜺2  -- -- -- -- (4.7) 
MMT = δ0 + δ1HEXP + δ2RGDP) + 𝜺3 -- -- -- -- (4.8) 
RDGP = ϑ0 + ϑ1HEXP + ϑ2LEXP + ϑ3IFM + ϑ4MMT + ϑ5FTR + 𝜺5 (4.9) 
HEXP = σ0 + σ1RGDP + σ2LEXP + σ3IFM + σ4MMT + σ5FTR + 𝜺6 (4.10) 
The Toda and Yamamoto (1995) version of the above specified models representing the 
nexus among health expenditure, health outcomes and economic growth are in the following 
VAR system: 
 
 
 
 
 
(4.11) 
(4.12) 
(4.13) 
(4.14) 
(4.15) 
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Where: 
LEXP = Life Expectancy 
IFM = Infant Mortality 
MMT = Maternal Mortality Rate 
HEXP = Health Expenditure 
RGDP = Real Gross Domestic Product (Proxy for Economic Growth) 
α, β, δ, θ, ϑ and σ = Coefficients of the independent variables 
γit = White Noise Stochastic Error Term  
4.2 Empirical Analysis 
4.2.1 Preliminary Analysis 
4.2.1.1 Descriptive Statistics 
Table 4.1 presents the descriptive characteristics of the macroeconomic variables used in this 
study. The average value of health expenditure, infant mortality, life expectancy, maternal mortality 
rate and real GDP are N58.85 billion, 105.78 per 1000 live births, 47.91 years, 364.95 per 1000 
female adults and N32749.95 billion respectively. This suggests that maternal mortality rate 
is still very high in Nigeria and infant mortality is as well relatively high indicating that more 
women than children die in the course of child birth. This suggests that there is a dire need to 
upgrade the child delivery facilities in the country to lower the incidence of maternal and 
infant mortality. The mean values of health expenditure and real GDP also show that the 
percentage of government expenditure on health is extremely low and this could be the 
reason for the high maternal and infant mortality rate in Nigeria. 
Furthermore, the probability values of the Jarque-Bera statistic of each variable show that the 
all the variables are normally distributed given the probability value of the Jarque-Bera 
statistic. In addition, for a series to be said to be normally distributed, the value of skewness 
should be zero or not be statistically different from zero. Accordingly, all the variables except 
health expenditure meet this condition thus giving further credence to the assertion of normal 
distribution. Further, all the variables employed in this study are platykurtic except health 
expenditure which is leptokurtic given its kurtosis value. The result also shows that all the 
variables have a very high standard deviation signifying a high deviation from their 
respective mean values. 
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Table 4.1: Descriptive Statistics 
 HEXP IFM LEXP MMT RGDP 
 Mean 58.85 105.78 47.91 364.95 32749.95 
 Median 15.22 115.20 46.13 360.32 22449.41 
 Maximum 257.72 126.20 53.72 393.74 69023.93 
 Minimum 0.04 65.50 45.64 331.45 13779.26 
 Std. Dev. 82.51 21.58 2.67 15.54 18889.20 
 Skewness 1.26 0.61 0.97 0.14 0.80 
 Kurtosis 3.10 1.81 2.40 2.68 2.14 
 Jarque-Bera 9.79 4.46 6.37 0.27 5.10 
 Probability 0.1075 0.1074 0.1414 0.8749 0.1781 
 Sum 2177.54 3913.70 1772.74 13502.97 1211748.00 
Observations 37 37 37 37 37 
Where HEXP = Health Expenditure; IFM = Infant Mortality; LEXP = Life Expectancy; MMT = Maternal 
Mortality Rate; and RGDP = Real Gross Domestic Product 
Source: Author‟s Computation from Eviews9 
4.2.1.2 Unit Root Test 
Routinely, the time-series properties of macroeconomic variables need to be ascertained when 
carrying out time-series analysis so as to guard against obtaining spurious results. The 
appropriate test for checking these time-series properties is unit root test. It tests the null 
hypothesis of the presence of unit root as against the alternative hypothesis of the absence of 
unit root. The decision rule is that the null hypothesis will be rejected and be alternative 
hypothesis accepted should the computed t-statistic be greater than the test critical values in 
absolute terms or the probability value be less than 0.1; it will be accepted and be alternative 
hypothesis rejected should the computed t-statistic be less than the test critical values in 
absolute terms or its probability value be greater than 0.1 or 10 per cent significance level. 
This study employs the Augmented Dickey-Fuller (ADF) unit root test method to check the 
order of integration of the macroeconomic variables of this study and the results are presented 
in Table 4.2. The results show that infant mortality and life expectancy are stationary at level 
[I(0)] while health expenditure, maternal mortality rate and real GDP are stationary at first 
difference [I(1)]. This result shows that the macroeconomic variables employed in this study 
are a combination of I(0) and I(1) series or are integrated of different orders. This condition 
makes the ARDL Bounds test approach to cointegration appropriate for investigating the 
long-run relationship among these variable.  
Table 4.2: Unit Root Test Results 
 Augmented Dickey Fuller (ADF) 
 Level First Difference I(d) 
HEXP -1.27c -2.94a** I(1) 
IFM -4.58*b - I(0) 
LEXP -3.67*b - I(0) 
MMT -0.96a -3.78b* I(1) 
RGDP -1.86b -5.45b* I(1) 
Note: *, ** and ***  represent statistical significance at 1%, 5% and 10% level respectively; „a‟ denotes model 
with constant and „b‟ is for model with trend and constant and trend. I(0) and I(1) indicate stationarity at level 
and first difference respectively. 
Source: Author‟s Computation from Eviews9 
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4.2.1.3 ARDL Bounds Test Approach to Cointegration 
In line with the result of the unit root test, cointegration test will be carried out using ARDL 
Bounds Test approach to cointegration. The choice of this approach is premised on the fact 
that our variables are integrated of different orders [(I(0) and I(1)], thus negating the use of 
Engle-granger and Johansen Cointegration test approach. Pesaran and Shin (1999) and 
Pesaran et al (2001) developed the ARDL cointegration approach which has three major 
advantages over other traditional cointegration approaches. Firstly, the ARDL framework 
does not require that all the variables under study be of the same order of integration; it 
accommodates series which are I(0) or I(1) or both. Secondly, it is relatively more efficient 
using small sample sizes. Thirdly, the ARDL framework obtains unbiased estimates of the 
long-run model.  
The rule of ARDL Bounds test of cointegration states that the null hypothesis should be 
rejected if the value of the computed F-statistic is greater than the upper bounds value and 
accepted if the F-statistic is less than the lower bounds value. The ARDL cointegration test 
will be said to be inconclusive should the computed F-statistic fall within the lower and upper 
bound. Accordingly, Table 4.3 shows that the computed F-statistic (4.54) falls above the 
upper bound critical value at 5 and 10 percent level of significance. This implies that there is 
a long-run relationship among health expenditure, infant mortality, life expectancy, maternal 
mortality rate and real GDP. 
Table 4.3: ARDL Bounds Test Result 
Significance 
Level 
Critical Value Computed F-
Statistics Lower (I0) Bound Upper (I0) Bound 
1% 
5% 
10%  
3.74 
2.86 
2.45 
5.06 
4.01 
3.52 
 
4.54 
The Bounds critical values for k=5are obtained from Narayan (2005) case III for 40 observations. 
Source: Author‟s Computation from Eviews9 
4.2.2 Result of Toda-Yamamoto Granger Causality Test 
This study employs the Toda-Yamamoto Granger Causality approach examine the direction 
of causal relationship among health expenditure, health outcomes and economic growth in 
Nigeria. Before carrying out the Toda-Yamamoto granger causality test, it is needful to 
estimate the highest order of integration (dmax) in the system which is derived from the result 
of the unit root test. A cursory look at the unit root test result in Table 5.2 reveals that the 
maximum order of integration is one which implies that there will be an additional one lag to 
the VAR models. The next step after ascertaining the maximum order of integration is to 
determine the optimal lag length of the VAR model which is determined using the following 
criterions: sequential modified LR test statistic (LR), Final Prediction Error (FPE), Akaike 
Information Criterion (AIC), Schwarz Information Criterion (SC) as well as the Hannan 
Quinn (HQ) Information Criterion. Accordingly, the result of the VAR optimal lag length 
selection criteria is presented in Table 5.4. It is obvious that the various information criteria 
unanimously suggested the selection of a maximum lag length of 3 for each variable thus, the 
VAR model with lag length 3 will be estimated.  
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Table 4.4: VAR Lag Length Selection Criteria 
Endogenous variables: HEXP IFM LEXP MMT RDGP 
 Lag LogL LR FPE AIC SC HQ 
0  106.1440 NA   1.01e-09 -6.525417 -6.294128 -6.450023 
1  389.6865  457.3267  5.89e-17 -23.20558 -21.81785 -22.75322 
2  451.8915  80.26451  6.13e-18 -25.60590 -23.06173 -24.77657 
3  504.8231  51.22415*  1.49e-18* -27.40794* -23.70733* -26.20164* 
4  585.4645   52.02672  1.03e-19 -30.99771 -26.14066 -29.41443 
Where * indicates lag order selected by the criterion, LR = sequential modified LR test statistic (each 
test at 5% level), FPE = Final prediction error, AIC = Akaike information criterion, SC = Schwarz 
information criterion and HQ = Hannan-Quinn information criterion 
Source: Author‟s Computation from Eviews9 
 
The results of Toda-Yamamoto causality estimated by the modified Wald test are presented 
in Table 4.5. The results show that the test follows the chi-square distribution with 3 degrees 
of freedom which is in accordance with optimal lag length. The results of the Toda-
Yamamoto causality test reveal that the null hypothesis that health expenditure does not 
granger causes infant mortality is rejected thus, health expenditure granger causes infant 
mortality in Nigeria while infant mortality does not granger cause health expenditure 
suggesting that there is a unidirectional causal relationship running from health expenditure 
to infant mortality. This result is plausible and in line with a priori expectation. It suggests 
that the health expenditure in Nigeria has been able to achieve a desired result (reduction in 
infant mortality) and that the effort of government and other stakeholder in the heath sector 
have not been in vain. This result is also consistent with findings by Novignon, Olakojo and 
Nonvignon (2012), Kulkarni (2016), Edeme, Emecheta and Omeje (2017). Also, real GDP 
does not granger cause infant mortality neither does infant mortality granger cause real GDP 
indicating that there is no causality between real GDP and infant mortality in Nigeria.  
Moreover, the result shows that health expenditure granger causes life expectancy while life 
expectancy does not granger cause health expenditure indicating that there is a unidirectional 
causality running from health expenditure to life expectancy. This suggests that health 
expenditure by the government has been able to improve the life expectancy at birth in 
Nigeria and that government‟s effort at improving the health sector of the Nigerian economy 
is yielding the desired result. This result in line with a priori expectation and parallels the 
findings of Maduka, Madichie and Ekesiobi (2006), Kim and  Lane (2013), Jaba, Balana and 
Robu (2014) but negates the findings of Ogungbenle, Olawumi and Obasuyi (2013). 
Similarly, real GDP granger causes life expectancy while life expectancy does not granger 
cause real GDP thus, indicating that there is a unidirectional causal relationship running from 
real GDP to life expectancy. This result is against the findings of Ogungbenle, Olawumi and 
Obasuyi (2013) who found a bidirectional causality running from real GDP to life expectancy 
and vice versa.  
Besides, there is a unidirectional causal relationship between health expenditure and maternal 
mortality rate in Nigeria as causality runs from health expenditure to maternal mortality rate 
but not the other way round. This result implies that health expenditure in Nigeria has been 
able to weakly combat maternal mortality given the probability value that is very close to 10 
percent. Similarly, whereas real GDP granger causes maternal mortality, maternal mortality 
does not granger cause real GDP in Nigeria thus, suggesting a unidirectional causality 
running from real GDP to maternal mortality. This result is plausible and in line with a priori 
expectations as it implies that as the economy grows, maternal mortality rate reduces. This is 
the case in most developed economies and it can be attributed to the improvement in 
technology that has led to the invention of modern machines with which to preserve lives. 
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More so, health expenditure does not granger cause real GDP but real GDP granger causes 
health expenditure in Nigeria suggesting that a there is a unidirectional causality running 
from real GDP to health expenditure in Nigeria. This suggests that economic growth is 
capable of increasing health expenditure or economic growth is capable of influencing the 
amount the government will spend on the health sector in Nigeria. This result is plausible and 
is in line with theoretical expectation. 
Summarily, health expenditure has a significant causal relationship with infant mortality, 
maternal mortality and life expectancy in Nigeria. In the same vein, real GDP has a 
significant causal relationship with maternal mortality and life expectancy in Nigeria. These 
results indicate that health expenditure has a significant causal relationship with health 
outcomes in Nigeria and the direction of relationship is unidirectional such that causality runs 
from health expenditure and health outcomes. This implies that the little efforts of the 
government in funding the health sector of the Nigerian economy are gradually yielding the 
desired fruit. On the other hand, real GDP causes/influences health outcomes in Nigeria and 
not the other way round. A unidirectional causality runs from real GDP to health outcomes in 
Nigeria. Finally, the result shows that it is real GDP that granger causes health expenditure 
and not the other way round. 
Table 4.5: Toda-Yamamoto Causality (modified Wald) Test Results 
Null Hypotheses Chi-sq Df Prob. Direction of 
Causality 
HEXP does not granger cause IFM 1.59 3 0.0136 Unidirectional 
HEXP  IFM IFM does not granger cause HEXP 0.81 3 0.8145 
     
RGDP does not granger cause IFM 1.27 3 0.7358 No Causality 
IFM does not granger cause RGDP 2.29 3 0.5147  
     
HEXP does not granger cause LEXP 7.53 3 0.0568 Unidirectional 
HEXP  LEXP LEXP does not granger cause HEXP 3.39 3 0.3353 
     
RGDP does not granger cause LEXP 20.16 3 0.0002 Unidirectional 
RGDP  LEXP LEXP does not granger cause RGDP 1.06 3 0.7860 
     
HEXP does not granger cause MMT 13.62 3 0.0035 Unidirectional 
HEXP  MMT MMT does not granger cause HEXP 0.67 3 0.8797 
     
RGDP does not granger cause MMT 5.03 3 0.0142 Unidirectional 
RDGP  MMT MMT does not granger cause RGDP 0.10 3 0.9918 
     
HEXP does not granger cause RGDP 2.40 3 0.4944 Unidirectional 
RDGP  HEXP RGDP does not granger cause HEXP 11.49 3 0.0093 
Source: Author‟s Computation from Eviews9 
 
4.2.3 Diagnostic / Post-Estimation Test 
Before this result can be appropriate for policy formulation and/or prescription, it is needful 
to verify that the estimates of the chosen multivariate model are reliable. This will require 
diagnostic checks / post-estimation tests. The most relevant post-estimation test for 
multivariate models is the serial correlation test (using the LM test). It is carried out to test 
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the presence of serial correlation in the estimated model thus, the null hypothesis of the serial 
correlation test is: “No Serial Correlation at Lag Order h.” The null hypothesis will be 
accepted if the probability value is greater than 10 percent and rejected of the probability 
value is less than 10 percent. Accordingly, Table 4.6 presents the result of the Serial 
Correlation LM test and it shows that the probability values of the LM-Stat for each lag is 
greater than 10 percent thus, the null hypothesis of no serial correlation will be accepted 
indicating that the estimates of the model and its results are reliable for policy prescription.  
 
Table 4.6: Diagnostic Test 
VAR Residual Serial Correlation LM Tests 
Null Hypothesis: No Serial Correlation at Lag Order h 
Lags LM-Stat Prob 
1  30.88705  0.2236 
2  25.91344  0.4122 
3  32.48781  0.1444 
4  19.47508  0.7738 
5  15.79846  0.8241 
Source: Author‟s Computation from Eviews9 
 
5.0 Conclusion and Policy Implications 
The relationship between health expenditure, health outcomes and economic growth remains 
inconclusive in the extant literature hence, it is needful to ascertain these relationships so as 
to make evidence-based decision that would ameliorate the situation of the health sector of 
Nigeria. Given the high rate of infant and maternal mortality, the low life expectancy in 
Nigeria as well as the meagre budgetary allocation to the health sector of the Nigerian 
economy, it became imperative to examine the link between health expenditure, health 
outcomes and economic growth to actually see there is a causal relationship among these key 
macroeconomic variables in Nigeria.  
Hence, this study was carried out to examine the causal relationship as well as the direction 
of causality among health expenditure, health outcomes (infant mortality, life expectancy and 
maternal mortality) and economic growth in Nigeria using the ARDL Bounds test approach 
to cointegration and the Toda-Yamamoto causality test. Sequel to the empirical findings of 
this study, this study concludes that health expenditure and economic growth play key roles 
in determining the health outcomes in Nigeria. Specifically, causality runs from health 
expenditure to infant mortality, maternal mortality and life expectancy while causality runs 
from economic growth to life expectancy and maternal mortality. On the other hand, this 
study concludes that a unidirectional causal relationship exists between economic growth and 
health outcomes in Nigeria indicating that causality runs from economic growth to health 
expenditure. 
The implications of these findings for the Nigerian economy are hereby discussed. First, the 
non-causality between economic growth and infant mortality suggests that economic growth 
and infant mortality does not cause nor affect each other thus, that the government and the 
stakeholders in the health sector should endeavour to adopt technologies that would lower the 
incidence of infant mortality in Nigeria. Lastly, the unidirectional causality between health 
expenditure and economic growth as against the bidirectional causality found by Ogungbenle, 
Olawumi and Obasuyi (2013) suggests that the government need to formulate and implement 
policies that will stimulate economic growth which will in turn influence health expenditure, 
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thereby instigating the desired health outcomes. Second, the unidirectional causality running 
from economic growth to health expenditure suggests that health expenditure does not cause 
economic growth thus, downplaying the contribution of the health sector of the Nigerian 
economy to aggregate output. This implies that while government spends on health sector, it 
should focus on the impact of health expenditure on health outcomes rather than economic 
growth. It also suggests that health expenditure does not have a direct but indirect effect on 
economic growth as it goes through health outcomes to influence economic growth. 
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